
RightAnswer Knowledge Solutions provides access to hundreds of data sources. Our premier and proprietary sources include fully-researched documents from well-established experts in the chemical and HazMat fields.
A search in our system for this chemical would return results – all in one place -- in the following categories from the listed data sources.
- Chemical Identification
- Environmental Hazards
- First Aid/Medical Treatment
- Handling/Storage/Shipping/Waste Management
- Personal Protection
- Physical Hazards/Corrective Response Actions
| - Physical/Chemical Properties
- Regulatory/Standards/Labels
- Report Abstracts and Studies
- Reproductive Risk
- Toxicology/Health Hazards/Exposure
| Example of Acute Exposure data from MEDITEXT. |
RightAnswer Proprietary Data Sources:
HAZARDTEXT™ Documents
MEDITEXT® Documents
Other Government Links Searched via RegsKnowledge:
State Environmental Regulations

CFR Regulations

Example Content from MEDITEXT for 55981-09-4:
Please note: this is an extract of information from a larger document. Full document and details are available by subscription.
ACUTE EXPOSURE INFORMATION
- USES: Nitazoxanide oral suspension is used to treat diarrhea caused by Cryptosporidium parvum and Giardia lamblia in pediatric patients 1 to 11 years of age. Nitazoxanide oral tablets are used for the same indications in patients 12 years of age and older.
- PHARMACOLOGY: Nitazoxanide is an antiparasitic agent (nitrothiazole derivative) with antiprotozoal activity that appears to interfere with the pyruvate:ferredoxin oxidoreductase (PFOR) enzyme-dependent electron transfer reaction required for anaerobic energy metabolism.
- EPIDEMIOLOGY: Overdose is rare.
- WITH THERAPEUTIC USE
- COMMON: The most common adverse effects include abdominal pain, diarrhea, headache, nausea, vomiting.
- LESS FREQUENT: Although causality has not been established, other adverse effects that have been reported less frequently (less than 1%) include dizziness, somnolence, insomnia, tremor, hypesthesia, dyspepsia, anorexia, flatulence, constipation, dry mouth, thirst, discolored urine, dysuria, amenorrhea, menorrhagia, renal pain, labial edema, elevated SGPT, elevated creatinine (oral suspension), anemia, leukocytosis, rash, pruritus, eye discoloration, ear ache, epistaxis, lung disease, pharyngitis, tachycardia, syncope, hypertension, myalgia, leg cramps.
- WITH POISONING/EXPOSURE
- Specific overdose information is not available; however, single oral doses up to 4000 mg have been tolerated.
© 2011-2025 RightAnswer.com, Inc. and/or its licensors. All rights reserved. No claim to original U.S. Govt. works.